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Abstract  
Genomic alterations lead to cancer complexity and form a major hurdle for a 
comprehensive understanding of the molecular mechanisms underlying oncogenesis. In 
this review, we describe the recent advances in studying cancer-associated genes from a 
systems biological point of view. The integration of known cancer genes onto protein and 
signaling networks reveals the characteristics of cancer genes within networks. This 
approach shows that cancer genes often function as network hub proteins which are 
involved in many cellular processes and form focal nodes in the information exchange 
between many signaling pathways. Literature mining allows constructing gene-gene 
networks, in which new cancer genes can be identified. The gene expression profiles of 
cancer cells are used for reconstructing gene regulatory networks. By doing so, the genes, 
which are involved in the regulation of cancer progression, can be picked up from these 
networks after which their functions can be further confirmed in the laboratory.                       
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Cancer is an extremely complex, heterogeneous disease, which could display a degree of 
complexity at the physiological, tissue and cellular levels. The interactions between 
tumors and their microenvironments reflect the physiological complexity of cancers, 
which is the recent focus of the cancer research. Bidirectional interactions between 
cancer and its microenvironment might promote their growth, survive and the occurrence 
of distant metastasis [1], However, the molecular mechanisms underlying the interactions 
between cancer cells and their microenvironment are poorly understood. A cancer tissue 
or a tumor often contains several distinct pathological featured cancer subtypes, which is 
recognized as cancer tissue complexity. This tissue complexity is believed to provide 
functional redundancy for tumors to maintain cellular heterogeneity which could lead to 
tumor recurrence [2-4] as long as a cancer subtype or a fraction of cancer cells with 
metastatic potential survives after anticancer treatment. One cancer subtype is able to 
functionally replace another or even multiple subtypes, which were killed by medical 
treatments such as using anti-cancer drugs [5, 6]. The functional replacement of cancer 
subtypes allows tumor survival, further proliferation and finally tumor recurrence. It is 
reasonable to think that each cancer cell subtype within a tumor might originate through 
different cancer-specific-developmental mechanisms and mutations in distinct genes. 
Therefore, this complexity will require a combination of several drugs or treatments 
targeting various cancer cell subtypes within a tumor. In the past few years, successful 
progresses have been made to identify the molecular signatures of various cancer 
subtypes in tumors by performing large-scale gene expression profiling analyses using 
the microarray technology. For example, sets of gene expression signatures have been 
identified for breast cancer subtypes [7-9]. Nevertheless, for effective cancer treatment, it 
is necessary to identify those oncogenic signaling pathways that are the driving force for 
each of these cancer cell subtypes. However, linking cancer subtypes to the oncogenic 
signaling pathways and cascades is still hurdled by a poor understanding of the oncogenic 
processes at the cellular level. The co-existence of several cancer cell subtypes, which 
rely on the activation of different signaling pathways in one particular tumor, represents 
the tissue complexity of cancers, while the activation of multiple pathways that lead to 
the development of the same type of cancer represent the cellular complexity of cancers.  
Cancer cells have characteristics of uncontrolled cell growth, the ability to invade 
their surrounding tissues and finally to generate metastasis in distant places of human 
body. The accumulation of genetic mutations in part triggers tumor development and 
progression. Gene mutation or deregulation also promotes cell mobility that is highly 
correlated with tissue invasion and the formation of distant metastasis. In cancer, many 
kinds of gene alterations such as gene sequence mutations [10, 11], gene and 
chromosomal fragment amplifications, chromosomal translocations and gene fusions [12-
15], gene deletions [16, 17] and even the mutations and deregulations of noncoding 
RNAs such as microRNAs [18-20] have been studied and documented extensively. A 
recent genome-wide screening of cancer mutation genes revealed that different cancer 
clinical samples of a same cancer type contains different sets of mutated genes which 
have divergent functions, indicating that the mutated genes do not belong to a same 
pathway, and therefore, suggesting that a cancer could develop through multiple genetic 
routes [21]. Because gene activity and regulation that ultimately define a cancer 
phenotype, it is essential to get a comprehensive understanding of the precise genetic 
mutations and the consequences of these mutations and genetic alterations. Therefore, it 
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is not surprising that the majority of research efforts are focusing on the genomics, 
functional genomics and proteomics of cancer cell progression and metastasis.  
The complexity of the cancer forms a major obstacle for a comprehensive 
understanding of underlying molecular mechanisms of oncogenesis. No gene is an island. 
Even in a single cell, genes are interrelated to work together and take part in many 
biological processes which then determine the cell’s behavior and phenotype. Scientists 
have struggled for years to figure out how to handle this biological complexity. Systems 
biology, or more specifically network biology, is driven by the gradual realization that a 
particular biological function is not from the result of the activity encoded by one single 
gene. The goal of systems biology is to combine molecular information of various types 
in models to understand biological systems and their complexity, and finally attempt to 
predict biological function at the cellular, tissue, organ, and even whole-organism levels. 
The development of genomic technologies such as high-throughput sequencing, 
especially DNA, protein microarrays and mass spectrometry, has made it possible to 
describe cells’ biological states in a quantitative manner, and to simultaneously study 
many gene and protein components and then clarify how these components work together 
in regulation and carrying out biological processes. The integration of these experimental 
techniques with the information technology provides a powerful approach to address and 
dissect the complexity of cancer and other biological problems at various levels in a 
systems-manner.  
 
Biological understanding of cellular networks 
In cells, interdependent interactions of genes and proteins form complex cellular 
networks such as signaling networks, gene regulatory networks and metabolic networks. 
Cellular networks are the basis of biological complexity. Therefore, the cellular networks 
have become the core of systems biology. Traditionally, network and graph theory is a 
branch of mathematics. Here we briefly review and explain network and graph theory 
with a focus on biological insights. Recent developments in high-throughput techniques 
in the field of genomics and proteomics research generated vast amount of data, 
furthermore, electronic format information in literature is becoming accessible on 
internet. Extraction of these datasets and information used to generate new cellular 
networks or integrate onto and expand existing cellular networks makes it attractive to 
study the structures of these networks by relating them to biological properties and 
insights. Therefore, it is necessary to develop systematic methods for analyzing cellular 
networks as well as understanding their properties in a cellular context.  
In biology, cellular networks include protein interaction networks which encode 
the information of proteins and their physical interactions, signaling networks which 
illustrate inter- and intracellular communications and the information process between 
signaling proteins, gene regulatory networks which describe the regulatory relationships 
between transcription factors and/or regulatory RNAs and genes, and metabolic networks 
of biochemical reactions between metabolic substrates and products. Metabolic networks 
are not the focus in the review, however, more information about metabolic networks can 
be found in a recent review [22]. Subcellular networks include amino acid residue 
interaction networks in protein structures, which are assumed to involve a permanent 
flow of information between amino acids [23]. 
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Networks can be presented as either directed or undirected graphs. Protein 
interaction networks are modeled as undirected graphs, in which the nodes represent 
proteins and the links represent the physical interactions between the proteins. Directed 
graphs, on the other hand, are used to present gene regulatory and metabolic networks. In 
gene regulatory networks, nodes represent transcription factors or genes, while links 
represent regulatory relations between transcription factors and the regulated genes or 
transcription factors. Signaling networks are presented as graphs containing both directed 
and undirected links. In the networks nodes represent proteins, directed links represent 
the activation or inactivation relationships between proteins, while undirected links 
represent physical interactions between proteins. Comparing to other cellular networks, 
signaling networks are far more complex in terms of the relationships between proteins, 
for example, nodes may represent different functional proteins such as kinases, growth 
factors, ligands, receptors, adaptors, scaffolds, transcription factors and so on, which all 
have different biochemical functions and are involved in many different types of 
biochemical reactions that characterize a specific signal transduction machinery.  
In the past few years, significant progress has been made in the identification and 
interpretation of the structural properties of cellular networks. This information has shed 
light on how such properties might reflect the biological meanings and behaviors of 
cellular networks [24, 25]. Although each type of the cellular network has its own 
properties, they all share some common structural properties. Cellular networks and other 
real-world networks, such as a public transportation network exhibit a global structure 
property that is defined as “scale-free”. In a scale-free network, a small group of nodes 
act as highly connected hubs (high degree), whereas most nodes have only a few links 
(low degree). For example, a map describing the air transportation in the United States is 
a network, in which only a few big airports (hubs) in big cities such as Boston, New 
York, Chicago and Los Angles have many air routes (links) to other airports, while many 
small airports just have a few air routes to the nearby big airports. This common 
structural feature encodes a special property of these networks: they are robust but also 
very vulnerable to failure and attack [25]. In a scale-free network, randomly removal of a 
substantial fraction of the low degree nodes will make little damage on the network’s 
connectivity, however, targeted removal of the high degree hub nodes will easily 
disconnect and destroy the network completely, as illustrated by the air transportation 
map. Disabling big airports (hubs) will wreak havoc in many ways, while damaging a 
few small airports will have little or no effect on overall air transportation.  
In regulatory networks, hub genes are global transcription factors. They may 
govern a large amount of genes in response to internal and external signals. To fit their 
multiple biological functions, the hub’s expression will have to display dynamic 
characters. Analysis of the yeast gene regulatory network in which the gene expression 
profiles of many different cellular conditions were integrated, shows that the hub 
transcription factors do control a large spectrum of biological processes [26]. We have 
integrated a genome-wide mRNA decay data onto the E. coli gene regulatory network 
and revealed that the transcription factors whose mRNAs have fast decay rates are 
significantly enriched in hub genes, suggesting that the expression of the hub genes in 
gene regulatory networks are indeed highly dynamic. This dynamic behavior facilitates a 
rapid response of the network to external stimuli [27]. A similar result was obtained in a 
recent study, in which mRNA decay data were mapped onto the yeast protein interaction 
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network, showed that the hub proteins in protein interaction networks also display fast 
mRNA decay rates [28]. In protein interaction networks, hub proteins are involved in a 
large number of interactions, meaning that these proteins will take part in many 
biological processes and therefore would have higher dynamics in expression. 
Furthermore, hub proteins may be more important for an organism’s survival and have a 
much broader effect on a system than non-hub proteins. A series of reports confirm this 
notion [24, 29-32]. These reports also suggest that hub proteins have central positions in 
cellular networks and are more essential for the organism’s survival than other proteins. 
Therefore, the structure, or in another word, topology, of cellular networks not only sheds 
light on the complex cellular mechanisms and processes, but also gives insight into 
evolutionary aspects of the proteins involved. By examining protein evolution and protein 
interaction networks, Saeed and Deane found that hub proteins are “old” proteins which 
have evolved more slowly than other proteins [33]. Biologically this makes perfect sense, 
in that hub proteins are involved in many biological processes and are subject to selection 
pressure and constraints. Hub proteins in signaling networks are the focal nodes that are 
shared by many signaling pathways. In another word, hub proteins have become 
information exchanging and processing centers. Alterations to these hub proteins may 
therefore globally affect the well being of living cells. A recent RNAi screening of 
worms supports this hypothesis. Lehner et al. systematically mapped the genetic 
interactions of Caenorhabditis elegans genes involved in signaling pathways and 
revealed a network of 350 interactions [34]. They then tested 65,000 pairwise gene 
interactions and found that a few genes interact with an unexpectedly large number of 
signalling pathways. These hub genes were identified as chromatin-modifying proteins 
which are conserved across animals where they display core genetic buffering properties.  
Cellular networks are complex systems, in which a gene does not independently 
performing a single task, instead, individual genes can be grouped, which collaborate to 
carry out some specific biological function. We call such a gene group as a functional 
module. This assumption leads to the idea that a complex network can be broken up into 
many small but functional modules or units, which can be then studied to determine their 
structural properties and functional behaviors. Once we understand the functions, 
properties and regulatory/interaction behaviors of these modules, we can then use these 
functional modules to rebuild sub-networks and even whole networks and study their 
properties and functions. Network motifs are examples of such functional modules, 
which are the statistically significant recurring structural patterns or small subgraphs or 
sub-networks that are found more often in a real network than would be expected by 
chance [35]. These motifs are known as gene regulatory loops in biology. These motifs 
can self-organize or are forming a network by sharing nodes between various motifs [27]. 
Network motifs have been studied in details in gene regulatory networks. Three major 
motifs are found in gene regulatory networks: Single Input Module (SIM), bi-fan and 
Feedforward Loop (FFL) (Figure 1). One design principle of these motifs is that the 
transcription factors whose mRNAs have fast decay rates are significantly enriched in 
these motifs, suggesting that motif structures encode a regulatory behavior: network 
motifs are able to rapidly response to internal and external stimuli and decrease cell 
internal noise [27]. Network motifs have been shown to have distinct regulatory functions 
and are robust in that they are resistant to internal noise. Both theoretical and 
experimental studies have shown that network motifs bear distinct regulatory functions 
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and particular kinetic properties that determine the temporal program of gene expression 
[36]. Therefore, the frequencies and types of network motifs with which cells use reveal 
the regulatory strategies that are selected in different cellular conditions [27, 37, 38]. For 
example, FFLs are buffers that respond only to persistent input signals [39], which makes 
them well-suited for responding to endogenous conditions, while the motifs whose key 
regulator’s transcripts have a fast mRNA decay rate are preferentially used for 
responding to extraneous conditions [27]. In signaling networks, network motifs such as 
switches [40], gates [41], and positive or negative feedback loops provide specific 
regulatory capacities in decoding signal strength, processing information and controlling 
noise [42, 43]. 
Distinct network motifs could form large aggregated structures, called network 
themes that perform specific functions by forming collaborations between a large number 
of motifs [44]. In this case, network themes can be regarded as communities of 
functionally related nodes. A large protein complex in protein interaction networks is one 
of the examples of such network community.   
 
Integrative network analysis of cancer-associated genes 
High-throughput gene expression profiling often leads to the identification of a hundred 
or sometimes even thousands of modulated genes for a given phenotype. However, the 
extraction and interpretation of biological insights of the differientially expressed genes 
in these high-throughput datasets are challenging, and limited by the difficulties in 
recognizing the gene-gene relations and associations within the huge amount of data. 
Although it is possible to classify the identified genes into different functional groups 
using Gene Ontology (GO) [45], the in-depth relationships between genes in different 
functional categories can still not be easily illustrated. A particular phenotype is the result 
of collaborations of a group of genes, which are not necessary belonging to one same 
functional category. Therefore, integration of microarray generated gene lists onto 
cellular networks could help analyzing and interpreting the biological significance of the 
genes in a network and their gene-interdependent context. This notion provides a 
structured network knowledge-base approach to analyze genome-wide gene expression 
profiles in the context of known functional interrelationships among genes, proteins and 
phenotypes. 
Motivated by this concept, Wachi et al. investigated the differentially expressed 
genes in squamous cell lung cancer which were identified by projecting the microarray 
gene expression profiling onto a human protein interaction network [46]. The data for the 
network construction were taken from the online predicted human interaction database, 
(OPHID) [47], which contains 16,034 known human protein interactions obtained from 
various public protein interaction databases, and 23,889 additional protein interactions 
that were predicted. They mapped the 360 up-regulated and 270 down-regulated genes 
that were identified in the lung cancer microarray experiment onto the protein interaction 
network. Further network analysis revealed that the up-regulated genes in this dataset are 
well connected, whereas the suppressed genes and randomly selected genes are less so. 
They also showed that high degree of centrality in these differentially up-regulated genes, 
but not for the genes that are suppressed. These results imply that the up-regulated, but 
not down-regulated genes in this experiment are enriched in hub proteins, which are 
associated with essential functions in protein interaction networks [29]. Cancer cells are 
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characterized by uncontrolled growth, which could suggest that the induced genes in 
cancer cells, compare to normal cells, are more essential for survival and proliferation. 
The work described here uncovers the characteristics of cancer-associated genes in a 
network context and supports the notion that integrative network analysis of large 
datasets obtained from gene expression profiling helps understanding the functions of 
biological systems. 
The characteristics of cancer-associated genes uncovered in this study were 
confirmed by a recent analysis of a human protein interaction network integrated with 
literature-mined cancer genes.  Johsson and Bates [48] used mutated cancer genes 
collected from literature [49] and attempted to uncover their intrinsic properties in a 
human protein interaction network which was constructed from the entire human genome 
using an orthology-based method [50]. In total, 346 genes encoding 509 protein isoforms, 
were mapped on to the network. This analysis showed that cancer proteins have on 
average, twice as many interaction partners as other proteins in the network, which 
implies the evolutionary aspects of cancer genes. Accumulating evidence shows a 
positive correlation between the evolution of proteins and their number of interactions 
within a given network [31, 51, 52]. With this consideration in mind, the authors 
concluded that proteins, whose mutation results in a detrimental change of function that 
leads to cancer, may generally be more conserved than other proteins. Alternatively, 
cancer proteins, as they have more interaction partners, may be involved in significantly 
more biological processes and play a central role in the protein network. To further 
explore this direction, Johsson and Bates also investigated the relationships between these 
cancer genes and network communities, which represent a distinct biological process, 
meaning that if a protein is a member of multiple network communities, it takes part in 
more biological processes. The results of this analysis show that the identified cancer 
proteins are indeed involved in more network communities than other proteins in the 
network, suggesting their more prominent centrality and participation in the formation of 
the proteome network backbone. Taking it one step further, the authors also analyzed the 
domain compositions of these cancer proteins. Cancer proteins display a high ratio of 
highly promiscuous domains, in terms of the number of different proteins with which 
they interact, indicating that they play central roles in many biological processes and that 
mutations in these proteins could lead to a higher cancer incidence. Moreover, the 
domains most frequently found in the cancer protein population have functionalities that 
particularly focus on DNA regulation and repairing, such as Zinc-finger, PHD-finger, 
BRCT and Paired-box domains, which all happen to be transcription factors.  
These works provide a biological insight into the global protein interaction 
network properties of cancer proteins and uncover one of the most striking properties of 
cancer proteins in that cancer-associated proteins are network hubs, which play central 
roles in biological systems and take part in many biological processes. Taken together, 
each hub cancer protein may reflect a specific domain of a cellular function, which 
suggests that mutations of an individual or a few hub proteins together may lead to 
oncogenesis or cancer progression. However, these studies provide little insights into the 
oncogenic mechanisms simply because protein interaction networks have limited 
information compared to signaling networks in which protein regulatory (activation and 
blocking) information is encoded. Therefore, the integration of cancer genes onto the 
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existing and established signaling networks would be possible to get more insights into 
the oncogenic process and cancer progression. 
Cells use a sophisticated communication between proteins to perform a series of 
tasks such as growth and maintenance, cell survival, apoptosis and development. 
Signaling pathways are crucial to maintain cellular homeostasis and determine cell 
behavior. Therefore, alterations in the expression of genes and their regulators will reflect 
on these cellular signaling pathways which in turn lead to tumor development and/or the 
promotion of cell migration and metastasis. In deed, mutations in genes that encode 
signaling proteins are commonly observed in many types of cancers [53]. 
Specific signaling pathways deploy many different proteins, however, pathways 
often “talk” each other. This so called “cross-talk” between pathways has been 
systematically investigated in a recent study, and an unexpected high numbers of cross-
talk events between signaling pathways were discovered [54]. These results indicate that 
signaling pathways form a complex network to process information. Structural analysis 
of a literature-mined human cellular signaling network containing ~500 proteins, showed 
that signaling pathways are intertwined in order to manage the numerous cell behavior 
outputs [55]. This work provides a framework for our understanding of how signaling 
information is processed in cells. Furthermore, analysis of interactions between 
microRNAs and the same signaling network reveals the principles of microRNA 
regulation of the network [56]. Together, these approaches hint that an integrative 
analysis of signaling networks with cancer proteins would highlight the characteristics of 
cancer proteins within these signaling networks.       
Errors in signal transduction can lead to altered development and incorrect 
behavioral decisions which could result in uncontrolled cell growth or even cancer. The 
relationships of signaling proteins are thought to be critical in determining cell behavior, 
therefore the mapping of cancer genes on the nodes of a signaling network could general 
lead us to which mechanisms support the continued survival and proliferation of cancer 
cells. We manually curated human cellular signaling pathways and merged these curated 
data into another literature-mined human cellular signaling network mentioned 
previously [55]. As a result, the new network contains ~1,100 signaling proteins. Next 
the cancer proteins were obtained from NCBI’s Online Mendelian Inheritance in Man 
(OMIM) database [57] were mapped onto the network. Nearly 90 cancer proteins were 
mapped onto the network [58]. Not surprisingly, cancer proteins are enriched in hub 
proteins in the signaling network. As mentioned, cancer genes often get mutated, which 
could result in the activation of particular focal signaling nodes that play important roles 
in the information exchange between many individual signaling pathways. Indeed, 
several cancer proteins form the focal nodes in signaling networks and therefore play 
important roles in cancer development.   
The cellular signal information flow initiates from the extracellular space, e.g. a 
ligand binds to a cellular membrane receptor to generate the signal that is then 
transmitted by intracellular signaling components in cytosol to the signaling components 
within nucleus. This process of signal transduction is sensitive in terms of mutated genes, 
which result in altered signaling and therefore tumourgenesis, and increase cell mobility 
and invasion. We found that cancer proteins are enriched in the downstream section of 
signaling networks, the realm of the transcription factors [58]. Along with this discovery, 
we also found that cancer proteins are hardly represented in some particular network 
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motifs such as bi-fan (Figure 1), which is a structure with regulatory redundancy but also 
one of the most abundance network motifs in central region of the human signaling 
network. These results lead us to believe that the central region of a signaling network 
provides a genetic buffer for cells in that it may prevent cancer development, which is in 
agreement with the robustness of networks [59]. The fact that cancer proteins are 
enriched in the downstream region hints that proteins in this region are crucial for 
determining specific cell behavior. Our work provides insights into the signaling 
networks invoked in cancer development and progression. 
The systems-level approach taken in these works, i.e. combining information on 
how proteins interact with each other and how transmitted signals are processed, with 
information on known cancer genes and gene expression in cancer cells, is a particularly 
appealing approach to gain an understanding of complex biological processes, such as 
cancer development and metastasis. Network analyses using comprehensive knowledge 
of biology provide a framework for structuring the existing knowledge regarding cancer 
biology and help identifying proteins and/or significant functional modules and the 
underlying mechanisms of the oncogenic process.  
 
Hunting new cancer-related genes using cellular networks 
Protein interaction networks have been used to hunt new cancer-associated genes. 
Jonsson et al. have been motivated to find genes involved in metastasis by integrating 
cancer cell microarray expression data onto a rat protein interaction network which was 
constructed by transferring protein-protein interaction information from other species 
using the protein homology concept [50]. The network was evaluated by a confidence 
scores based on their homology to proteins that have been experimentally observed to 
interact. Metastasis is a key event that is usually associated with a poor prognosis in 
cancer patients. Metastasizing cancer cells have special properties, in that they can 
display features such as increased motility and invasiveness. 
It was hypothesized that sub-networks of protein interactions may govern the 
metastasis. Jonsson et al. used a data set containing the up- and down-regulated genes 
that was obtained from a cancer microarray study, and constructed sub-networks around 
proteins which was then evaluated using cluster analysis to define network communities 
that reflect small protein interaction units that are involved in the metastastic process 
[50]. As a result, they identified 37 protein communities of highly interconnected 
proteins, and of which most of them have been associated with cancer and metastasis. 
Gene networks have been constructed by merging various data sources which 
were then used to find or prioritize cancer and other disease genes. In this context, gene-
gene networks are presented using undirected graphs, in which the nodes represent genes 
and the links represent relations between genes. The relations of the genes can be protein 
physical interactions, gene regulatory relations, and gene associations and so on. Franke 
et al. constructed such a human gene-gene network using the databases of known 
interactions, GO, microarray co-expressions and yeast two-hybrid data [60]. They then 
integrated this network with already known genetic information of diseases (i.e. genetic 
loci for a particular human disease). The authors reasoned that the cancer genes from 
each locus are likely to be involved in one same molecular pathway and biological 
process. To prove their concept, they showed that the genes prominent in any one disease 
were closer to each other in the network than would be expected by chance, which 
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suggests that these genes are involved in the disease and therefore tend to have more 
functional interactions or associations. To assess the predictive power of this method, the 
authors tested it by picking disease genes using the network. Four out of 10 breast cancer 
genes were ranked in the top of the gene list, which is 4 times higher than a breast cancer 
gene that would be picked by chance. When they integrated more interaction data onto 
the network and adjusted the network topology, the ranking of these disease genes 
improved considerably, and included 9 of the 10 genes. These results indicate that the use 
of a network significantly improves the chance of finding the correct cancer genes. 
In the past few years, a series of studies focused on constructing gene-gene 
networks using data from literature and other sources. One notion behind this is that 
nearly 80% of biological information and data are coded in natural language in technical 
reports, web sites, research publications and other text documents [61]. To facilitate the 
extraction of these data, methods have been developed for the automatic extraction of 
interaction and pathway information from the scientific literature [62-66]. Furthermore, 
the extracted relations between genes have been used to construct gene-gene networks, 
and several software packages and related datasets have been developed. PubGene [67] is 
an example of such a tool, which contains a database and analysis software for 
constructing gene-gene networks by identifying relationships between genes based on 
their statistical co-occurrence in the abstracts of scientific papers. The Information 
Hyperlinked over Proteins (iHop) [68] is another example. In this case one can use gene 
names to retrieve gene-gene relations from PubMed abstracts that match a specified 
gene/protein name. iHop also provides automatic extraction gene-gene relations for 
software developers and bioinformatics scientists. 
Contrast to most of the text mining methods that use the abstracts of research 
papers, Natarajan et al. tried to use full-length scientific articles to extract gene-gene 
relations [69], and also fused the extracted gene interactions to structured data and 
knowledge bases such as Ingenuity Pathway Analysis, UniProt [70] , InterPro [71], NCBI 
Entrez and GO. A human gene-gene network was constructed using theses data sources. 
The authors then mapped the differentially expressed genes identified from microarray, 
which profiled the gene expression in glioblastoma as a response to S1P in vitro. Further 
analysis led to the identification of a cascading event that is triggered by S1P, and which 
leads to the transactivation of MMP-9 via neuregulin-1, vascular endothelial growth 
factor, and the urokinase-type plasminogen activator. This suggests that the interaction 
network has the potential to shed new light on our understanding of the cancer-related 
process. Therefore, automated extraction of information from biological literature, 
together with combining and integrating biological data from laboratory experiments, 
provides an effective way in biological knowledge discovery.  
 
Reverse engineering of gene regulatory networks from microarray data 
Reverse engineering of biological networks is a process of elucidating the structure of 
gene regulation relationships by reasoning backwards from the observations of gene 
expression values. In recent years, a substantial effort has been made to reconstruct gene 
regulatory networks using microarray profiles. Here we just describe two related work 
which combined computational and experimental approaches.  
Basso et al. developed a statistical algorithm using mutual information for more 
accurately reasoning networks in which pair-wise gene-gene interactions are described 
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[72]. The algorithm was named the Algorithm for the Reconstruction of Accurate 
Cellular Networks (ARACNE). To test ARACE, the authors used a huge number of gene 
expression profiles (336 samples) of human B-cell at different stages covering normal to 
cancer cells to construct a network. A sub-network was used for validation using GO and 
chip-on-chip experiments. The results are encouraging in that 90% specificity was 
obtained for ARACNE. However, we should be aware that the test did not include the 
predictions with lowest mutual information scores. Nevertheless, this approach shows 
that with “enough” gene expression data, reasonable gene networks can be retrieved by 
developing proper algorithms. 
Another example of the reverse engineering applied to cancer research was 
carried out using a dataset that was generated in our own laboratory. We constructed a 
gene regulatory network using the time course microarray profiles from a mouse 
epithelial breast cell line (BRI-JM01), which was isolated from mammary tumors in 
transgenic mice. These cells undergo an epithelial to mesenchymal transition (EMT) 
when they are treated with TGF-β [73]. To identify the transcriptional changes 
underlying this EMT, we exposed the BRI-JM01 cell line to TGF-β for 7 time intervals 
(0.5-24 h), and interrogated the transcriptome using cDNA microarrays. Based on the 
microarray profiles and the markov chain based network construction method [74], we 
constructed a gene regulatory network that contains nearly 50 genes and 3 layers of 
regulations, in which the regulatory relations are either direct or indirect (Lenferink et al., 
unpublished data, Figure 2). Known biological information was used to validate the 
network. Interestingly, in the top layer of the network, all the annotated genes are either 
transcription factors or signaling proteins, which are known as regulatory proteins. Most 
known genes in the bottom layer of the network are known to involve in cancer 
processes, which suggest that the network somewhat seems right. Notably, clusterin, one 
of the genes that are up-regulated in the middle and late time-points shows many 
regulatory links to other genes in the network. During the EMT process, clustrerin is 
secreted by the BRI-JM01 cells. Interestingly, when applying anti-clusterin antibodies to 
the TGF-β treated BRI-JM01 cells, we were able to block the TGF-β induced EMT. This 
result strongly implies that the secreted form of clusterin plays a pivotal role in the TGF-
β induced EMT and therefore TGF-β’s tumor promoting effects on the BRI-JM01 cell 
line. Currently, reverse engineering of gene regulatory networks using microarray data is 
mainly hurdled by limited microarray experiments we could perform for a given sample. 
Reverse engineering methods only provide some hints to biologists, although they could 
narrow down the gene list of interest. A substantial lab experiments should be followed to 
further validate the genes of interest from the inferred gene regulatory networks.              
 
Outlook 
The analysis of the cancer phenomenon using a systems-level approach is still in its 
infant shoes. New and emerging technologies need to be developed and validated. 
These technologies include single cell signaling mapping, which will be very helpful in 
obtaining the full picture of signaling dynamics occurring in different cancer cells and 
during various stages of cancer development. These techniques will be especially useful 
for understanding the biology of tumors which consist of notoriously heterogeneous 
cancer cell populations. The information of relations between genes and/or proteins is 
still limited, but will be alleviated once new high-throughput datasets become available. 
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These new datasets either generated experimentally or by literature mining will no doubt 
provide information on new interactions between genes. Current efforts are ongoing to 
curate high quality signaling data from literature [75, 76].  
Overall, the systems biology output will bring unprecedented amounts of 
molecular information and large-scale datasets to medicine in the form of DNA 
sequences and quntative information of mRNAs, proteins, and metabolites. An important 
part of systems biology is taking all of these measurements in consideration to construct 
models to describe what is going on in a cell, a tissue, an organ, or even an organism. A 
systmes-level understanding the underlying mechanism causing cancer in an individual 
cancer patient will allow science to become more focused and will contribute 
significantly to the clinical application of a personalized medication.
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Figure legends: 
 
Figure 1. Network motifs in gene regulatory networks.  
Nodes represent genes and lines represent gene regulatory relations. A, Single Input 
Module (SIM): a transcription factor (TF) regulates a group of genes (G1, G2, G3 and 
G4). B, Feedforward Loop (FFL): a transcription factor (TF1) regulates the second 
transcription factor (TF2), both TF1 and TF2 regulate a target gene (G1). C, Bi-fan: both 
transcription factors TF1 and TF2 regulate both target genes (G1 and G2).  
 
Figure 2. A gene regulatory network inferred from the time course gene expression 
profiles of BRI-JM01 cell line. Nodes represent genes and lines represent gene regulatory 
relations. 
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